Epigral Ltd. (EPIGRAL) - Total Assets
Based on the latest financial reports, Epigral Ltd. (EPIGRAL) holds total assets worth Rs35.05 Billion INR (≈ $379.08 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Epigral Ltd. - Total Assets Trend (2015–2026)
This chart illustrates how Epigral Ltd.'s total assets have evolved over time, based on quarterly financial data. Also see EPIGRAL market cap overview for the company's overall valuation and market capitalisation.
Epigral Ltd. - Asset Composition Analysis
Current Asset Composition (March 2026)
Epigral Ltd.'s total assets of Rs35.05 Billion consist of 23.6% current assets and 76.4% non-current assets. Review Epigral Ltd. balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.2% |
| Accounts Receivable | Rs4.17 Billion | 11.9% |
| Inventory | Rs3.49 Billion | 10.0% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs155.00 Million | 0.4% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2015–2026)
This chart illustrates how Epigral Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Epigral Ltd. stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Epigral Ltd.'s current assets represent 23.6% of total assets in 2026, an increase from 15.9% in 2015.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2026, up from 0.1% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 11.9% of total assets.
Epigral Ltd. Competitors by Total Assets
Key competitors of Epigral Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Senior Technology Material Co Ltd
SHE:300568
|
China | CN¥25.67 Billion |
|
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150
|
China | CN¥2.28 Billion |
|
Guangzhou Lingwe Technology Co. Ltd. A
SHE:301373
|
China | CN¥1.94 Billion |
|
Guangdong Rongtai Industry Co Ltd
SHG:600589
|
China | CN¥3.63 Billion |
|
Darbond Technology Co. Ltd. A
SHG:688035
|
China | CN¥3.42 Billion |
|
Jingsu Jingshen Salt&Chem
SHG:603299
|
China | CN¥13.88 Billion |
|
GRIPM Advanced Materials Co. Ltd. A
SHG:688456
|
China | CN¥2.38 Billion |
|
Shandong Kaisheng New Materials Co.Ltd.
SHE:301069
|
China | CN¥2.49 Billion |
Epigral Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.57 | 0.47 |
| Quick Ratio | 0.67 | 0.79 | 0.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs1.16 Billion | Rs2.83 Billion | Rs-2.07 Billion |
Epigral Ltd. - Advanced Valuation Insights
This section examines the relationship between Epigral Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.19 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 11.2% |
| Total Assets | Rs35.05 Billion |
| Market Capitalization | $515.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Epigral Ltd.'s assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Epigral Ltd.'s assets grew by 11.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Epigral Ltd. (2015–2026)
The table below shows the annual total assets of Epigral Ltd. from 2015 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs35.05 Billion ≈ $379.08 Million |
+11.19% |
| 2025-03-31 | Rs31.52 Billion ≈ $340.92 Million |
+12.82% |
| 2024-03-31 | Rs27.94 Billion ≈ $302.20 Million |
+14.89% |
| 2023-03-31 | Rs24.32 Billion ≈ $263.04 Million |
+14.53% |
| 2022-03-31 | Rs21.24 Billion ≈ $229.67 Million |
+46.59% |
| 2021-03-31 | Rs14.49 Billion ≈ $156.67 Million |
+13.76% |
| 2020-03-31 | Rs12.73 Billion ≈ $137.72 Million |
+21.95% |
| 2019-03-31 | Rs10.44 Billion ≈ $112.93 Million |
+55.66% |
| 2018-03-31 | Rs6.71 Billion ≈ $72.55 Million |
+27.16% |
| 2017-03-31 | Rs5.28 Billion ≈ $57.05 Million |
-2.28% |
| 2016-03-31 | Rs5.40 Billion ≈ $58.39 Million |
+1.06% |
| 2015-03-31 | Rs5.34 Billion ≈ $57.78 Million |
-- |
About Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power pl… Read more